Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis

Journal of Critical Care

Volumn 39, Issue , 2017, Pages 87-96

  Sy, Eric ^a,b,d   Sklar, Michael C ^c   Lequier, Laurence ^e   Fan, Eddy ^c,f   Kanji, Hussein D ^d  

^a REGINA GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Anticoagulants; Extracorporeal membrane oxygenation; Heparin; Meta analysis; Systematic review

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; EXTRACORPOREAL OXYGENATION; HOSPITAL MORTALITY; HUMAN; META ANALYSIS; NEWCASTLE-OTTAWA SCALE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; SYSTEMATIC REVIEW; THROMBOEMBOLISM; VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION; BLOOD CLOTTING; CLINICAL PRACTICE; FEMALE; MORTALITY; PHYSIOLOGY;

ANTICOAGULANTS; BLOOD COAGULATION; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; PRACTICE PATTERNS, PHYSICIANS'; PREVALENCE; THROMBOEMBOLISM;

EID: 85017653974     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2017.02.014     Document Type: Article

References (58)

1. [1] Abrams, D., Combes, A., Brodie, D., Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. J Am Coll Cardiol 63 (2014), 2769–2778, 10.1016/j.jacc.2014.03.046.
2. [2] Esponda, O., Tafur, A., Management of pulmonary embolism: state of the art treatment and emerging research. Curr Treat Options Cardiovasc Med 15 (2013), 137–152, 10.1007/s11936-013-0229-6.
3. [3] Maggio, P., Hemmila, M., Haft, J., Bartlett, R., Extracorporeal life support for massive pulmonary embolism. J Trauma 62 (2007), 570–576, 10.1097/TA.0b013e318031cd0c.
4. [4] Makdisi, G., Wang, I.-W., Extra corporeal membrane oxygenation (ECMO) review of a lifesaving technology. J Thorac Dis 7 (2015), E166–E176, 10.3978/j.issn.2072-1439.2015.07.17.
5. [5] Marasco, S.F., Lukas, G., McDonald, M., McMillan, J., Ihle, B., Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. Heart Lung Circ 17:Suppl. 4 (2008), S41–S47, 10.1016/j.hlc.2008.08.009.
6. [6] Ruttmann, E., Weissenbacher, A., Ulmer, H., Müller, L., Höfer, D., Kilo, J., et al. Prolonged extracorporeal membrane oxygenation–assisted support provides improved survival in hypothermic patients with cardiocirculatory arrest. J Thorac Cardiovasc Surg 134 (2007), 594–600, 10.1016/j.jtcvs.2007.03.049.
7. [7] Reynolds, M.M., Annich, G.M., The artificial endothelium. Organogenesis 7 (2011), 42–49, 10.4161/org.7.1.14029.
8. [8] Esper, S.A., Levy, J.H., Waters, J.H., Welsby, I.J., Extracorporeal membrane oxygenation in the adult: a review of anticoagulation monitoring and transfusion. Anesth Analg 118 (2014), 731–743, 10.1213/ANE.0000000000000115.
9. [9] Annich, G.M., Lynch, W.R., MacLaren, G., Wilson, J.M., Bartlett, R.H., Extracorporeal cardiopulmonary support in critical care. 4th ed., 2012, The Extracorporeal Life Support Organization, Ann Arbor, Michigan.
10. [10] Tran, B.G., De La Cruz, K., Grant, S., Meltzer, J., Benharash, P., Dave, R., et al. Temporary venoarterial extracorporeal membrane oxygenation: ten-year experience at a cardiac transplant center. J Intensive Care Med, 2016, 10.1177/0885066616654451.
11. [11] Lequier, L., Annich, G., Al-Ibrahim, O., Bembea, M., Brodie, D., Brogan, T., et al. ELSO anticoagulation guideline. 2014, 1–17 [ https://www.elso.org/portals/0/files/elsoanticoagulationguideline8-2014-table-contents.pdf].
12. [12] Kasirajan, V., Smedira, N.G., McCarthy, J.F., Casselman, F., Boparai, N., McCarthy, P.M., Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 15 (1999), 508–514.
13. [13] Mateen, F.J., Muralidharan, R., Shinohara, R., PArisi, J., Schears, G., Wijdicgks, E., Neurological injury in adults treated with extracorporeal membrane oxygenation. Arch Neurol 68 (2011), 1543–1549, 10.1001/archneurol.2011.209.
14. [14] ECMO, Registry of the Extracorporeal Life Support Organization (ELSO). [Ann Arbor, Michigan], 2016.
15. [15] Cheng, R., Hachamovitch, R., Kittleson, M., Patel, J., Arabia, F., Moriguchi, J., et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg 97 (2014), 610–616, 10.1016/j.athoracsur.2013.09.008.
16. [16] Lazzara, R.R., Magovern, J.A., Benckart, D.H., Maher, T.D., Sakert, T., Magovern, G.J., Extracorporeal membrane oxygenation for adult post cardiotomy cardiogenic shock using a heparin bonded system. ASAIO J 39 (1993), M444–M447.
17. [17] Lamarche, Y., Chow, B., Bédard, A., Johal, N., Kaan, A., Humphries, K.H., et al. Thromboembolic events in patients on extracorporeal membrane oxygenation without anticoagulation. Innovations (Philadelphia, Pa.) 5 (2010), 424–429, 10.1097/IMI.0b013e3182029a83.
18. [18] Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses. Ann Intern Med 151 (2014), 264–269, 10.1371/journal.pmed1000097.
19. [19] Wells, G., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available from URL http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp, 2012 doi: 10.2307/632432.
20. [20] Dersimonian, R., Laird, N., Meta-analysis in clinical trials*. Control Clin Trails 7 (1986), 177–188, 10.1016/0197-2456(86)90046-2.
21. [21] Barendregt, J.J., Doi, S.A., Lee, Y.Y., Norman, R.E., Vos, T., Meta-analysis of prevalence. J Epidemiol Community Health 67 (2013), 974–978, 10.1136/jech-2013-203104.
22. [22] Higgins, J.P.T., Thompson, S.G., Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002), 1539–1558, 10.1002/sim.1186.
23. [23] Aubron, C., Cheng, A.C., Pilcher, D., Leong, T., Magrin, G., Cooper, D.J., et al. Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study. Crit Care, 17, 2013, R73, 10.1186/cc12681.
24. [24] Bakhtiary, F., Keller, H., Dogan, S., Dzemali, O., Oezaslan, F., Meininger, D., et al. Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. J Thorac Cardiovasc Surg 135 (2008), 382–388, 10.1016/j.jtcvs.2007.08.007.
25. [25] Biocina, B., Petricevic, M., Belina, D., Gasparovic, H., Svetina, L., Konosic, S., et al. Results of extracorporeal life support implementation in routine clinical practice: single center experience. Croat Med J 55 (2014), 600–608, 10.3325/cmj.2014.55.600.
26. [26] Brunet, J., Valette, X., Ivascau, C., Lehoux, P., Sauneuf, B., Dalibert, Y., et al. Extracorporeal life support for refractory cardiac arrest or shock: a 10-year study. ASAIO J 61 (2015), 676–681, 10.1097/MAT.0000000000000282.
27. [27] Darocha, T., Kosiński, S., Jarosz, A., Sobczyk, D., Gałązkowski, R., Piątek, J., et al. The chain of survival in hypothermic circulatory arrest: encouraging preliminary results when using early identification, risk stratification and extracorporeal rewarming. Scand J Trauma Resusc Emerg Med, 24, 2016, 85, 10.1186/s13049-016-0281-9.
28. [28] Daubin, C., Lehoux, P., Ivascau, C., Tasle, M., Bousta, M., Lepage, O., et al. Extracorporeal life support in severe drug intoxication: a retrospective cohort study of seventeen cases. Crit Care, 13, 2009, R138, 10.1186/cc8017.
29. [29] Hoechter, D.J., Von Dossow, V., Winter, H., Müller, H.H., Meiser, B., Neurohr, C., et al. The Munich lung transplant group: intraoperative extracorporeal circulation in lung transplantation. Thorac Cardiovasc Surg 63 (2015), 706–714, 10.1055/s-0035-1556873.
30. [30] Kawahito, K., Ino, T., Adachi, H., Ide, H., Mizuhara, A., Yamaguci, A., Heparin coated percutaneous cardiopulmonary support for the treatment of circulatory collapse after cardiac surgery. ASAIO J 40 (1994), 972–976.
31. [31] Kim, D.H., Kim, J.B., Jung, S.H., Choo, S.J., Chung, C.H., Lee, J.W., Extracorporeal cardiopulmonary resuscitation: predictors of survival. Korean J Thorac Cardiovasc Surg 49 (2016), 273–279, 10.5090/kjtcs.2016.49.4.273.
32. [32] Lim, J.H., Hwang, H.Y., Yeom, S.Y., Cho, H.-J., Lee, H.-Y., Kim, K.-B., Percutaneous extracorporeal membrane oxygenation for graft dysfunction after heart transplantation. Korean J Thorac Cardiovasc Surg 47 (2014), 100–105, 10.5090/kjtcs.2014.47.2.100.
33. [33] Lim, J.Y., Kim, J.B., Choo, S.J., Chung, C.H., Lee, J.W., Jung, S.H., Anticoagulation during extracorporeal membrane oxygenation; nafamostat mesilate versus heparin. Ann Thorac Surg 102 (2016), 534–539, 10.1016/j.athoracsur.2016.01.044.
34. [34] Magovern, G.J., Adult placenta: the ECMO experience in patients with a coronary artery bypass graft and post cardiotomy cardiogenic shock. ASAIO J 42 (1996), 19–23 [doi:8808452].
35. [35] Malekan, R., Saunders, P.C., Yu, C.J., Brown, K.a., Gass, A.L., Spielvogel, D., et al. Peripheral extracorporeal membrane oxygenation: comprehensive therapy for high-risk massive pulmonary embolism. Ann Thorac Surg 94 (2012), 104–108, 10.1016/j.athoracsur.2012.03.052.
36. [36] Ranucci, M., Ballotta, A., Kandil, H., Isgrò, G., Carlucci, C., Baryshnikova, E., et al. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation. Crit Care, 15, 2011, R275, 10.1186/cc10556.
37. [37] Smith, C., Bellomo, R., Raman, J.S., Matalanis, G., Rosalion, A., Buckmaster, J., et al. An extracorporeal membrane oxygenation–based approach to cardiogenic shock in an older population. Ann Thorac Surg 71 (2001), 1421–1427, 10.1016/S0003-4975(00)02504-2.
38. [38] Staudacher, D.L., Biever, P.M., Benk, C., Ahrens, I., Bode, C., Wengenmayer, T., Dual antiplatelet therapy (DAPT) versus no antiplatelet therapy and incidence of major bleeding in patients on venoarterial extracorporeal membrane oxygenation. PLoS One, 11, 2016, e0159973, 10.1371/journal.pone.0159973.
39. [39] Wang, J.G., Han, J., Jia, Y.X., Zeng, W., Hou, X.T., Meng, X., Outcome of veno-arterial extracorporeal membrane oxygenation for patients undergoing valvular surgery. PLoS One, 8, 2013, 10.1371/journal.pone.0063924.
40. [40] Wang, S., Chen, Y., Ko, W., Chu, S., Extracorporeal membrane oxygenation support for postcardiotomy cardiogenic shock. Artif Organs 20 (1996), 1287–1291.
41. [41] Wu, M.Y., Lin, P.J., Lee, M.Y., Tsai, F.C., Chu, J.J., Chang, Y.S., et al. Using extracorporeal life support to resuscitate adult postcardiotomy cardiogenic shock: treatment strategies and predictors of short-term and midterm survival. Resuscitation 81 (2010), 1111–1116, 10.1016/j.resuscitation.2010.04.031.
42. [42] Yeo, H.J., Kim, D.H., Jeon, D., Kim, Y.S., Cho, W.H., Low-dose heparin during extracorporeal membrane oxygenation treatment in adults. Intensive Care Med 41 (2015), 2020–2021, 10.1007/s00134-015-4015-7.
43. [43] Yie, K., Chon, S.-H.D., Na, C.-Y., Activated clotting time test alone is inadequate to optimize therapeutic heparin dosage adjustment during post-cardiopulmonary resuscitational extracorporeal membrane oxygenation (e-CPR). Perfus (United Kingdom) 31 (2015), 307–315, 10.1177/0267659115604710.
44. [44] Yu, K., Long, C., Hei, F., Li, J., Liu, J., Ji, B., et al. Clinical evaluation of two different extracorporeal membrane oxygenation systems: a single center report. Artif Organs 35 (2011), 733–737, 10.1111/j.1525-1594.2010.01173.x.
45. [45] Zhao, Y., Xing, J., Du, Z., Liu, F., Jia, M., Hou, X., Extracorporeal cardiopulmonary resuscitation for adult patients who underwent post-cardiac surgery. Eur J Med Res, 20, 2015, 83, 10.1186/s40001-015-0179-4.
46. [46] Dalton, H.J., Garcia-Filion, P., Holubkov, R., Moler, F.W., Shanley, T., Heidemann, S., et al. Association of bleeding and thrombosis with outcome in extracorporeal life support*. Pediatr Crit Care Med 16 (2015), 167–174, 10.1097/PCC.0000000000000317.
47. [47] Hanson, S.R., Chapter 15 device thrombosis and thromboembolism. Cardiovasc Pathol 2 (1993), 157–165, 10.1016/1054-8807(93)90056-8.
48. [48] Glick, D., Dzierba, A.L., Abrams, D., Muir, J., Eisenberger, A., Diuguid, D., et al. Clinically suspected heparin-induced thrombocytopenia during extracorporeal membrane oxygenation. J Crit Care 30 (2015), 1190–1194, 10.1016/j.jcrc.2015.07.030.
49. [49] Gray, B.W., Haft, J.W., Hirsch, J.C., Annich, G.M., Hirschl, R.B., Bartlett, R.H., Extracorporeal life support: experience with 2,000 patients. ASAIO J 61 (2015), 2–7, 10.1097/MAT.0000000000000150.
50. [50] Aso, S., Matsui, H., Fushimi, K., Yasunaga, H., In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation: analysis of 5,263 patients using a national inpatient database in Japan. Crit Care, 20, 2016, 80, 10.1186/s13054-016-1261-1.
51. [51] Smith, A., Hardison, D., Bridges, B., Pietsch, J., Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation. Perfusion 28 (2013), 54–60, 10.1177/0267659112457969.
52. [52] Annich, G.M., Lynch, W.R., MacLaren, G., Wilson, J.M., Bartlett, R.H., ECMO: extracorporeal cardiopulmonary support in critical care. 4th ed., 2012, Extracorporeal Life Support Organization, Ann Arbor, Michigan.
53. [53] Agerstrand, C.L., Burkart, K.M., Abrams, D.C., Bacchetta, M.D., Brodie, D., Blood conservation in extracorporeal membrane oxygenation for acute respiratory distress syndrome. Ann Thorac Surg 99 (2015), 590–595, 10.1016/j.athoracsur.2014.08.039.
54. [54] Voelker, M.T., Busch, T., Bercker, S., Fichtner, F., Kaisers, U.X., Laudi, S., Restrictive transfusion practice during extracorporeal membrane oxygenation therapy for severe acute respiratory distress syndrome. Artif Organs 39 (2015), 374–378, 10.1111/aor.12385.
55. [55] Chu, D.C., Abu-Samra, A.G., Baird, G.L., Devers, C., Sweeney, J., Levy, M.M., et al. Quantitative measurement of heparin in comparison with conventional anticoagulation monitoring and the risk of thrombotic events in adults on extracorporeal membrane oxygenation. Intensive Care Med 41 (2015), 369–370, 10.1007/s00134-014-3574-3.
56. [56] Bembea, M.M., Schwartz, J.M., Shah, N., Colantuoni, E., Lehmann, C.U., Kickler, T., et al. Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation. ASAIO J 59 (2013), 63–68, 10.1097/MAT.0b013e318279854a.
57. [57] Liveris, A., Bello, R. a, Friedmann, P., Duffy, M. a, Manwani, D., Killinger, J.S., et al. Anti–factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*. Pediatr Crit Care Med 15 (2014), e72–e79, 10.1097/PCC.0000000000000028.
58. [58] Park, J.-H., Her, C., Min, H.-K., Kim, D.-K., Park, S.-H., Jang, H.-J., Nafamostat mesilate as a regional anticoagulant in patients with bleeding complications during extracorporeal membrane oxygenation. Int J Artif Organs 38 (2015), 595–599, 10.5301/ijao.5000451.